{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mastitis-breast-abscess/management/management-non-lactating-women/","result":{"pageContext":{"chapter":{"id":"95e2db4c-1f7a-5dfe-b04b-5edb440448bd","slug":"management-non-lactating-women","fullItemName":"Scenario: Management - non-lactating women","depth":2,"htmlHeader":"<!-- begin field 47a36bec-28ed-4008-b7db-a78200be76b5 --><h2>Scenario: Management of mastitis and breast abscess in non-lactating women</h2><!-- end field 47a36bec-28ed-4008-b7db-a78200be76b5 -->","summary":"Covers the management of mastitis in non-lactating women.","htmlStringContent":"<!-- begin item 294b6ff9-082a-4b00-9784-a78200be7423 --><!-- begin field b413b12f-4f8f-4c51-9817-acd900ab853d --><p>From age 14 years onwards (Female).</p><!-- end field b413b12f-4f8f-4c51-9817-acd900ab853d --><!-- end item 294b6ff9-082a-4b00-9784-a78200be7423 -->","topic":{"id":"612445a9-31b6-5130-bb99-4389c0f9c4af","topicId":"8dd98aac-dd7a-4981-bb01-5e666b4686b6","topicName":"Mastitis and breast abscess","slug":"mastitis-breast-abscess","lastRevised":"January 2021","chapters":[{"id":"d054cbf1-e596-5afd-8a75-f3d051c621dc","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"de83cb42-8301-5164-81a9-f0c4ab5a83c2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"610b1eb8-dd62-5e7e-b3bf-deb28c7072aa","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c44cbf7c-02c4-5674-abb6-1c6be6131e3b","slug":"changes","fullItemName":"Changes"},{"id":"9d333c13-3643-5811-9a29-a919983994aa","slug":"update","fullItemName":"Update"}]},{"id":"f993c606-c828-51da-a43a-6029a7e07f40","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a4f11480-406f-5573-9e6b-b2747a513a11","slug":"goals","fullItemName":"Goals"},{"id":"5020b6cc-9441-50c0-b8dd-94fcf8bdf761","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"948e09e3-ff32-5344-a06f-e0a9331eff4f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e253dff2-3341-5c3a-8c2c-a8c5c9d27491","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7a7fe239-eefb-5a7a-936c-c1c01d919b6e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"844a01a3-e6d9-5962-905c-52aaa284973a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"13965c3c-cc8a-575f-8e2d-056c9590196a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"edd589e4-be3e-52d6-b1ea-c2095f08f38e","slug":"definition","fullItemName":"Definition"},{"id":"06b05f0c-3f18-5d1a-994a-02d388348b53","slug":"causes","fullItemName":"Causes"},{"id":"ac2b0ec4-d2dd-5b82-999f-aa4fb681433e","slug":"predisposing-factors","fullItemName":"Predisposing factors"},{"id":"033ddd74-dfdc-5a2d-bb82-453baebee36f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9ccd068b-aec1-59bb-a0dc-497e330227b3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"bf45f222-3e69-50c6-b73f-cd089ff22c65","slug":"complications","fullItemName":"Complications"}]},{"id":"1facde51-ce1f-55fa-889f-f079ac8b1283","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4d19871b-504c-5d1d-8e27-298e0a8e40b2","slug":"when-to-suspect-mastitis","fullItemName":"When to suspect mastitis"},{"id":"1a7eb0d1-33d6-539d-bfc3-0b12f1ec6451","slug":"when-to-suspect-a-breast-abscess","fullItemName":"When to suspect a breast abscess"},{"id":"3478864a-a09e-5e3f-ab1e-bd6dc34d0ae1","slug":"investigations","fullItemName":"Investigations"},{"id":"f70b7f79-5c5c-5a9d-a586-dad7ec33698c","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1bdc74c8-e4f7-574c-a93a-ea9103718273","fullItemName":"Management","slug":"management","subChapters":[{"id":"7d9d079a-de35-5f76-8cfe-4303cce22c3e","slug":"management-lactating-women","fullItemName":"Scenario: Management - lactating women"},{"id":"95e2db4c-1f7a-5dfe-b04b-5edb440448bd","slug":"management-non-lactating-women","fullItemName":"Scenario: Management - non-lactating women"},{"id":"d1bd1c0d-5efe-5925-92a2-57663e0af1d5","slug":"management-breast-abscess","fullItemName":"Scenario: Management - breast abscess"}]},{"id":"d2222456-9dbf-5408-9e2a-d06f803d315e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"02c4d465-606a-5a45-bb76-7884e6655d29","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"35a080bd-68dc-5e30-8e45-c15b80ad6691","slug":"erythromycin-claithromycin","fullItemName":"Erythromycin and claithromycin"},{"id":"3354cafa-cf61-54b5-8be9-14286cac7d43","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"6882319d-cec4-58ac-a5fb-bfad5a8c44b5","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"5ca61020-4e7e-58c8-89de-963d0f9fad55","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"cdcf64dc-7d30-54dc-a4b3-c2cbb2e11318","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9ed2bf1e-0ab0-5318-ab26-7125ea334bc2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a07ffae7-9042-5683-b005-a39cb64cfe07","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3647fb21-13e1-5087-8638-500053de452d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d3f0e67e-27f7-5dab-bf77-6fd2fb6c04aa","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"c1eba960-eb26-5c75-a69c-d1b75d6bb18b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e3453acf-65bd-5b33-854f-a6e08be6d75c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1bdc74c8-e4f7-574c-a93a-ea9103718273","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"d962276f-7348-5b7b-8d54-2ee992829bcb","slug":"indications-for-immediate-admission-or-referral","fullItemName":"Indications for immediate admission or referral","depth":3,"htmlHeader":"<!-- begin field 49df4a24-80d1-4a1e-8c30-a78200be76ba --><h3>When should I arrange immediate admission or referral for a woman with non-lactational mastitis?</h3><!-- end field 49df4a24-80d1-4a1e-8c30-a78200be76ba -->","summary":null,"htmlStringContent":"<!-- begin item be80e4a0-4185-4081-8f38-a78200be76ba --><!-- begin field f76a9e59-bdef-436d-8d29-a78200be76ba --><ul><li><strong>Arrange hospital admission if:</strong><ul><li>There are signs of sepsis (such as tachycardia, fever, and chills).</li><li>The infection progresses rapidly.</li><li>The woman is haemodynamically unstable or immunocompromised.</li></ul></li><li><strong>Arrange urgent 2-week wait referral if</strong> there is an underlying mass or <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/diagnosis/differential-diagnosis/\">breast cancer</a> is suspected.</li><li><strong>Refer urgently to a general surgeon if</strong> a <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/diagnosis/when-to-suspect-a-breast-abscess/\">breast abscess</a> is suspected.</li></ul><!-- end field f76a9e59-bdef-436d-8d29-a78200be76ba --><!-- end item be80e4a0-4185-4081-8f38-a78200be76ba -->","subChapters":[{"id":"cdfdb9cd-dad1-5a65-aeff-6d0021957318","slug":"basis-for-recommendation-8ec","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a912f646-6d08-47d4-b376-a78200be76bf --><h4>Basis for recommendation</h4><!-- end field a912f646-6d08-47d4-b376-a78200be76bf -->","summary":null,"htmlStringContent":"<!-- begin item 8ece46d5-ea8c-46b7-bfea-a78200be76bf --><!-- begin field 9c851957-9cfa-4c2f-81a0-a78200be76bf --><p>The information on the management of non-lactational mastitis is largely based on expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>], a review article <em>Acute mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>], as well as extrapolated from guidelines on the management of women with lactational mastitis, including the World Health Organization (WHO) guideline <em>Mastitis. Causes and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>], the National Institute for Health and Care Excellence (NICE) guideline <em>Postnatal care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2015</a>], and the Academy of Breastfeeding Medicine (ABM) guideline <em>ABM Clinical protocol number 4: mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>].</p><h5>Arranging hospital admission</h5><ul><li>The recommendations on when to arrange admission are based on expert opinion in the Academy of Breastfeeding Medicine (ABM) guideline <em>ABM Clinical protocol number 4: mastitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>] and in BMJ Best Practice guideline <em>Mastitis and breast abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li></ul><h5>Arranging an urgent 2-week wait referral</h5><ul><li>The recommendation to consider arranging an urgent 2-week wait referral where breast cancer is suspected is based on expert opinion in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2020</a>].<ul><li>NICE advises a 2-week wait referral for all women aged 30 years and over with an unexplained breast lump, with or without pain.</li><li>NICE advises that non-urgent referral can be considered for women aged under 30 years with an unexplained breast lump, with or without pain.</li></ul></li></ul><h5>Urgent referral for a suspected abscess</h5><ul><li>This recommendation has been extrapolated from expert opinion in the WHO guideline <em>Mastitis. Causes and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>] and in review articles on the management of breast inflammation and infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Mass, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Betzold, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Spencer, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>].<ul><li>In women with a breast abscess, antibiotics alone without removal of pus are unlikely to be curative [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>Even when clinical examination shows signs of an abscess, an ultrasound is useful because it may identify more than one collection of pus that may otherwise be missed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>].</li></ul></li></ul><!-- end field 9c851957-9cfa-4c2f-81a0-a78200be76bf --><!-- end item 8ece46d5-ea8c-46b7-bfea-a78200be76bf -->","subChapters":[]}]},{"id":"fcfab055-d240-5096-8959-e4b34a43775c","slug":"first-line-management","fullItemName":"First-line management","depth":3,"htmlHeader":"<!-- begin field 80d4b435-07b9-46f3-b740-a78200c10426 --><h3>How should I manage a woman with non-lactational mastitis in primary care?</h3><!-- end field 80d4b435-07b9-46f3-b740-a78200c10426 -->","summary":null,"htmlStringContent":"<!-- begin item f9e82f9e-9667-4d86-854f-a78200c10212 --><!-- begin field e151d401-bdc7-43d1-a3ae-a78200c10426 --><p><strong>If immediate <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#indications-for-immediate-admission-or-referral\">admission or referral</a> is not indicated:</strong></p><ul><li><strong>Reassure the woman </strong>that her breast should return to normal size, shape, and function after adequate treatment.</li><li><strong>To relieve pain and discomfort:</strong><ul><li>Prescribe a simple analgesic, such as paracetamol or ibuprofen. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> for detailed information on prescribing these analgesics.</li><li>Advise the woman to place a warm compress on the breast, or bathe or shower in warm water, to relieve pain.</li></ul></li><li><strong>Identify and manage any <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/background-information/predisposing-factors/#mastitis-non-lactating-women\">predisposing factors</a> for mastitis.</strong> For example, if there is nipple damage, manage the underlying cause:<ul><li>If a candidal infection is suspected, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-body-groin/\">Fungal skin infection - body and groin</a> for information on management.</li><li>If eczema is suspected, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> and <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for information on management.</li><li>If Raynaud's disease of the nipple is suspected, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/breastfeeding-problems/\">Breastfeeding problems</a> for information on management.</li></ul></li><li><strong>Prescribe an oral antibiotic for <em>all</em> women with non-lactational mastitis:</strong><ul><li>Prescribe co-amoxiclav 500/125 mg three times a day for 10–14 days.</li><li>If the woman is allergic to penicillin, prescribe a combination of erythromycin (250–500 mg four times a day) or clarithromycin (500 mg twice a day) <em>plus</em> metronidazole (500 mg three times a day) for 10–14 days.</li></ul></li><li><strong>Advise the woman to seek immediate medical advice if </strong>symptoms worsen or fail to settle after 48 hours of antibiotic treatment. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#treatment-failure-recurrence\">Treatment failure/recurrence</a> for further information.</li><li><strong>Give advice on <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#preventing-failure-recurrence\">measures to prevent recurrence</a>.</strong></li></ul><!-- end field e151d401-bdc7-43d1-a3ae-a78200c10426 --><!-- end item f9e82f9e-9667-4d86-854f-a78200c10212 -->","subChapters":[{"id":"801cf56c-8061-588a-8615-d21fad0a2ca5","slug":"basis-for-recommendation-a66","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7d78c356-d35b-44e8-868e-a78200c1042a --><h4>Basis for recommendation</h4><!-- end field 7d78c356-d35b-44e8-868e-a78200c1042a -->","summary":null,"htmlStringContent":"<!-- begin item a6650106-6a78-459f-90ec-a78200c1042a --><!-- begin field 16131bbb-1501-443d-86f8-a78200c1042a --><p>The information on the management of non-lactational mastitis is largely based on expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>] and a review article <em>Acute mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>], as well as extrapolated from guidelines on the management of women with lactational mastitis, including World Health Organization (WHO) guideline <em>Mastitis. Causes and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>], the National Institute for Health and Care Excellence (NICE) guideline <em>Postnatal care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2015</a>], and the Academy of Breastfeeding Medicine (ABM) guideline <em>ABM Clinical protocol number 4: mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>].</p><h5>Symptomatic relief</h5><ul><li><strong>Analgesia</strong><ul><li>Paracetamol and ibuprofen are recommended as simple analgesia for mastitis as they are widely used for this purpose in a variety of conditions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BNF, 2021</a>].</li></ul></li><li><strong>Warm compress or bathe or shower with warm water </strong><ul><li>These recommendations are extrapolated from expert opinion on the management of lactational mastitis in the WHO guideline <em>Mastitis. Causes and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>], the WHO textbook <em>Infant and young child feeding: Model chapter for textbooks for medical students and allied health professionals </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>], the Health Service Executive Ireland <em>Mastitis: Fact sheet for Health Care Professionals </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Health Service Executive Ireland, 2017</a>], and the BMJ Best Practice guideline <em>Mastitis and Breast Abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li></ul></li></ul><h5>Identifying and managing predisposing factors</h5><ul><li>The recommendation to identify and manage predisposing factors is pragmatic, based on what CKS considers to be good clinical practice and is also extrapolated from expert opinion on the management of lactational mastitis in the NICE guideline <em>Postnatal care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2015</a>], the ABM guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>], and a review article published in the BMJ [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Amir, 2014</a>].<ul><li>Nipple damage from a pierced nipple or skin conditions such as psoriasis, eczema, infection, and Raynaud's disease of the nipple could provide an entry point for bacteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Amir, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>CKS has provided a link to the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/breastfeeding-problems/\">Breastfeeding problems</a> for information on the management of Raynaud's disease because the information can be extrapolated to non-lactating women.</li></ul></li></ul><h5>Antibiotic choice</h5><ul><li>Expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>] is that because it can be very difficult to differentiate between infectious and non-infectious non-lactational mastitis at an early stage, antibiotics should be prescribed in all cases.</li><li>For non-lactating women, CKS recommends co-amoxiclav first-line, with a combination of clarithromycin or erythromycin plus metronidazole as an alternative for women who are allergic to penicillin.<ul><li>This is because unlike in lactational mastitis where the majority of infections are caused by <em>Staphylococcus aureus </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>], organisms associated with infectious mastitis in non-lactating women include <em>S. aureus</em>, enterococci, and anaerobic bacteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>]. Co-amoxiclav is a beta-lactamase inhibitor with a broad spectrum of activity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BNF, 2021</a>] which is more suitable for empirical use in a situation where there is a lower degree of certainty about the likely causative organism.</li><li>For women who are allergic to penicillin, metronidazole is added to a macrolide for anaerobic cover.</li><li>These antibiotic choices are also in-line with expert opinion in the review article <em>Treatment of breast infection </em>published in the BMJ [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>] and the review article <em>Acute mastitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>], which states that periductal mastitis should be treated empirically with co-amoxiclav and that where a woman cannot use co-amoxiclav, another antibiotic plus metronidazole should be used.</li></ul></li></ul><h5>Length of antibiotic treatment</h5><ul><li>Although the duration of antibiotic treatment has not been subject to controlled trials, expert opinion in the WHO guideline <em>Mastitis. Causes and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>] and the ABM guideline <em>ABM Clinical protocol number 4: mastitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>] is that antibiotics should be prescribed for 10–14 days as a relapse is more common with shorter courses of treatment. This duration is also recommended for the treatment of mastitis by NICE and Public Health England (PHE) in the document <em>Summary of antimicrobial prescribing guidance – managing common infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE and PHE, 2020</a>].</li></ul><h5>Advising on measures to prevent recurrence</h5><ul><li>This recommendation is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field 16131bbb-1501-443d-86f8-a78200c1042a --><!-- end item a6650106-6a78-459f-90ec-a78200c1042a -->","subChapters":[]}]},{"id":"e4fb993e-b058-5a67-8eab-15948e4948a9","slug":"treatment-failure-recurrence","fullItemName":"Treatment failure/recurrence","depth":3,"htmlHeader":"<!-- begin field 12b93527-a078-4ab4-a698-a78200c12e5d --><h3>How should I manage treatment failure or recurrence in a woman with non-lactational mastitis?</h3><!-- end field 12b93527-a078-4ab4-a698-a78200c12e5d -->","summary":null,"htmlStringContent":"<!-- begin item 6a60da19-f0dc-4b4e-8c0d-a78200c12d07 --><!-- begin field 4369437b-ff32-4028-b14e-a78200c12e5d --><ul><li><strong>If symptoms fail to settle after 48 hours of <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#first-line-management\">first-line antibiotic treatment</a>:</strong><ul><li>Check that the woman has taken the antibiotic correctly.</li><li>Consider the possibility of an <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/diagnosis/differential-diagnosis/\">alternative diagnosis</a> (such as <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/diagnosis/differential-diagnosis/\">breast cancer</a> or a <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/diagnosis/when-to-suspect-a-breast-abscess/\">breast abscess</a>) and refer accordingly.<br><ul><li>If an abscess is suspected, be aware that malaise and fever may have subsided if antibiotics have been started.</li></ul></li><li>Also consider the possibility of methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) infection (risk factors include local prevalence and hospital-acquired infection) where first-line treatment is ineffective.<ul><li>If MRSA is suspected, seek local microbiology advice regarding possible investigations and treatments.</li></ul></li><li>Consider the need for <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#indications-for-immediate-admission-or-referral\">referral or admission</a>.</li></ul></li><li><strong>If mastitis recurs, </strong>manage as for <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#treatment-failure-recurrence\">treatment failure</a>. In addition:<ul><li>Check that previous episodes of mastitis were managed appropriately.</li><li>If an alternative diagnosis is unlikely:<ul><li>Prescribe co-amoxiclav 500/125 mg three times a day for 10–14 days.</li><li>If the woman is allergic to penicillin, prescribe a combination of erythromycin (250–500 mg four times a day) or clarithromycin (500 mg twice a day) <em>plus</em> metronidazole (500 mg three times a day) for 10–14 days.</li><li>If antibiotic treatment has failed more than once, seek advice from a local microbiologist regarding culture and sensitivity testing and/or alternative antibiotic treatment, and consider the possibility of an alternative diagnosis.</li></ul></li><li>Identify and manage any <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/background-information/predisposing-factors/#mastitis-non-lactating-women\">predisposing factors</a>, such as:<ul><li>Nipple damage from skin conditions such as psoriasis, eczema, infection, or Raynaud's disease of the nipple — see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#first-line-management\">First-line management</a> for more information.</li><li><em>S. aureus</em> carriage — send nasal swabs from the woman to identify nasal carriage of <em>S. aureus</em>. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/boils-carbuncles-staphylococcal-carriage/\">Boils, carbuncles, and staphylococcal carriage</a> for further information.</li></ul></li><li>Ensure that the woman is aware of <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/management/management-non-lactating-women/#preventing-failure-recurrence\">measures to prevent recurrence</a>, such as stopping smoking and maintaining good hygiene.</li><li>Consider referring the woman to secondary care (using clinical judgement to determine the urgency) if there is no obvious <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/background-information/predisposing-factors/#mastitis-non-lactating-women\">cause for recurrence</a> (such as continued smoking or nipple piercing).</li></ul></li></ul><!-- end field 4369437b-ff32-4028-b14e-a78200c12e5d --><!-- end item 6a60da19-f0dc-4b4e-8c0d-a78200c12d07 -->","subChapters":[{"id":"f02ca56c-7179-57c3-b0e9-3c879d5e3b61","slug":"basis-for-recommendation-b87","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4afb3d27-d0f0-47fd-a616-a78200c12e62 --><h4>Basis for recommendation</h4><!-- end field 4afb3d27-d0f0-47fd-a616-a78200c12e62 -->","summary":null,"htmlStringContent":"<!-- begin item b87fc223-3f5b-47c3-bc72-a78200c12e62 --><!-- begin field 510d85f6-88c5-472b-af70-a78200c12e62 --><p>The information on the management of treatment failure/recurrence in non-lactational mastitis is largely based on expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>] and a review article <em>Acute mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>], as well as extrapolated from guidelines on the management of women with lactational mastitis, including the World Health Organization (WHO) guideline <em>Mastitis. Causes and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>], the National Institute for Health and Care Excellence (NICE) guideline <em>Postnatal care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2015</a>], and the Academy of Breastfeeding Medicine (ABM) guideline <em>ABM Clinical protocol number 4: mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>].</p><h5>Checking that the woman has taken the antibiotic correctly</h5><ul><li>Expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess</em> is that infections should begin to respond to antibiotic treatment within 48 hours [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>Failure to complete an antibiotic course has been associated with a higher incidence of relapse and recurrence [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Deshpande, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>].</li></ul><h5>Considering an alternative diagnosis and the need for admission or referral</h5><ul><li>Expert opinion in review articles on the management of breast infections is that women whose symptoms do not settle after a course of antibiotics should be investigated for alternative diagnoses such as breast cancer or a breast abscess [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2013</a>]. Secondary care referral is therefore indicated.</li><li>The possibility of MRSA should also be considered where first-line antibiotic treatment has been ineffective, particularly if MRSA is locally prevalent or an infection may have been acquired in hospital [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>]. CKS pragmatically recommends that in such cases, advice should be sought from a local microbiologist regarding culture and sensitivity testing (depending on whether it is potentially possible to obtain a swab) and/or alternative antibiotic treatment.</li></ul><h5>Identifying and managing predisposing factors</h5><ul><li>The recommendation to identify and manage predisposing factors for mastitis is pragmatic, based on what CKS considers to be good clinical practice and is in-line with expert opinion relating to factors that are not specific to breastfeeding women in the NICE guideline <em>Postnatal care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">NICE, 2015</a>], the Academy of Breastfeeding Medicine (ABM) guideline <em>ABM Clinical protocol number 4: mastitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Academy of Breastfeeding Medicine, 2014</a>], and a review article published in the BMJ [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Amir, 2014</a>].<ul><li>Nipple damage resulting from a pierced nipple or skin conditions such as psoriasis, eczema, infection, and Raynaud's disease of the nipple could provide an entry point for bacteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Amir, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>Asymptomatic carriage of <em>Staphylococcus aureus</em> on a person's skin or mucous membranes (colonization) is implicated in recurrent infections. If mastitis recurs after a course of antibiotics, swabs should be taken from the woman's nose [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Betzold, 2007</a>].</li></ul></li></ul><h5>Antibiotic choice for recurrent infection</h5><ul><li>CKS recommends co-amoxiclav first-line, with a combination of clarithromycin or erythromycin plus metronidazole as an alternative for women who are allergic to penicillin.<ul><li>This is because the most common organisms associated with infectious mastitis in non-lactating women are <em>S. aureus</em>, enterococci, and anaerobic bacteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>]. Co-amoxiclav is a beta-lactamase inhibitor with a broad spectrum of activity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BNF, 2021</a>] which is generally suitable for empirical use in a situation where there is a low degree of certainty about the causative organism.</li><li>For women who are allergic to penicillin, metronidazole is added to a macrolide for anaerobic cover.</li></ul></li><li>These antibiotic choices are in-line with expert opinion in the review article <em>Treatment of breast infection </em>published in the BMJ [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>] and the review article <em>Acute mastitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>], which states that periductal mastitis should be treated empirically with co-amoxiclav and that where a woman cannot use co-amoxiclav, another antibiotic plus metronidazole should be used.</li><li>The suggestion that where antibiotic treatment has failed more than once, advice should be sought from a local microbiologist regarding culture and sensitivity testing (depending on whether it is potentially possible to obtain a swab) and/or alternative antibiotic treatment, or an alternative diagnosis should be considered, is pragmatic based on what CKS considers to be good clinical practice.</li></ul><h5>Secondary care referral if there is no obvious cause for recurrence</h5><ul><li>CKS recommends referral to secondary care if there is no obvious cause for recurrence (such as continued smoking or nipple piercing), because:<ul><li>Comedo-ductal carcinoma in situ may occasionally become infected and present with inflammation or as an abscess. An ultrasound or bilateral mammogram is therefore recommended to exclude this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>].</li><li>Recurrence is common after resolution of central/subareolar non-lactational infections because the underlying pathology in the central ducts often persist [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>]. The woman may need to undergo surgical excision of the affected duct to stop the cycle of recurrent infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>Granulomatous lobular mastitis has a high recurrence rate and can persist for months or years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li></ul></li></ul><!-- end field 510d85f6-88c5-472b-af70-a78200c12e62 --><!-- end item b87fc223-3f5b-47c3-bc72-a78200c12e62 -->","subChapters":[]}]},{"id":"4102d9f1-4455-561d-a32a-d2337a2f2eb9","slug":"preventing-failure-recurrence","fullItemName":"Preventing failure/recurrence","depth":3,"htmlHeader":"<!-- begin field b6c38c85-6e13-4fd1-a7fd-a78200c15245 --><h3>What advice should I give to prevent recurrence?</h3><!-- end field b6c38c85-6e13-4fd1-a7fd-a78200c15245 -->","summary":null,"htmlStringContent":"<!-- begin item 4a0949d3-1a92-46ac-8715-a78200c150a5 --><!-- begin field 10a03c22-bbe6-45ca-83c0-a78200c15245 --><ul><li><strong>Advise women who smoke to stop </strong>— smoking is a major risk factor for <a class=\"topic-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/background-information/causes/\">periductal mastitis</a>. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/smoking-cessation/\">Smoking cessation</a> for detailed information.</li><li><strong>Give advice on hygiene measures,</strong> including thorough and frequent hand washing and removal of nipple rings (due to potential bacterial contamination).</li></ul><!-- end field 10a03c22-bbe6-45ca-83c0-a78200c15245 --><!-- end item 4a0949d3-1a92-46ac-8715-a78200c150a5 -->","subChapters":[{"id":"6bbbf677-3c52-5b7a-97b6-fe52e4658a9b","slug":"basis-for-recommendation-fa7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f65aa805-02ac-4982-9883-a78200c15249 --><h4>Basis for recommendation</h4><!-- end field f65aa805-02ac-4982-9883-a78200c15249 -->","summary":null,"htmlStringContent":"<!-- begin item fa7b3c2b-e262-4910-9e3c-a78200c15249 --><!-- begin field c26a9610-5c94-4b3d-a5e2-a78200c15249 --><h5>Stopping smoking</h5><ul><li>Smoking is a major risk factor for periductal mastitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Blackmon, 2020</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li><li>Expert opinion in the review article <em>Treatment of breast infection</em> published in the British Medical Journal is that women who smoke should be advised of the risks of continued smoking and its association with recurrent breast infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">Dixon, 2011</a>].</li></ul><h5>Maintaining good personal hygiene</h5><ul><li>The World Health Organization (WHO) guideline <em>Mastitis. Causes and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">WHO, 2000</a>] states that reduction of the risk of infection is important to prevent recurrence of lactational mastitis. CKS has extrapolated this recommendation to also apply to non-lactating women.</li><li>Expert opinion in the BMJ Best Practice guideline <em>Mastitis and breast abscess </em>is that bacterial contamination of any foreign body (for example a nipple ring) is an indication for its removal [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mastitis-breast-abscess/references/\">BMJ Best Practice, 2020</a>].</li></ul><!-- end field c26a9610-5c94-4b3d-a5e2-a78200c15249 --><!-- end item fa7b3c2b-e262-4910-9e3c-a78200c15249 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}